Back to News
Market Impact: 0.7

S&P 500 Gains and Losses Today: Amex Stock Hits Record High; Oracle and Newmont Plunge

AXPKVUECOFGILDGSTFCNEMORCLMRNA
Corporate EarningsCompany FundamentalsAnalyst InsightsCommodities & Raw MaterialsConsumer Demand & RetailHealthcare & BiotechMarket Technicals & FlowsBanking & Liquidity
S&P 500 Gains and Losses Today: Amex Stock Hits Record High; Oracle and Newmont Plunge

American Express (AXP) shares surged 7.3% to an all-time high following strong quarterly earnings, driven by robust affluent consumer spending and high-end credit card refreshes. Conversely, Newmont (NEM) dropped 7.6% as gold prices retreated from record levels, while Oracle (ORCL) fell nearly 7% on analyst concerns regarding capital expenditure details and customer concentration. Moderna (MRNA) also declined 4.2% amid worries over declining vaccine revenue and limited product diversification, even as major U.S. equity indexes closed the week higher, shrugging off broader economic concerns.

Analysis

American Express (AXP) shares surged 7.3% to an all-time high, driven by a record $18.43 billion in revenue, an 11% year-over-year increase, which beat quarterly estimates. This strong performance was primarily attributed to a refresh of its high-end credit cards and robust spending from affluent consumers, indicating sustained strength in a key demographic. Broader market sentiment remained optimistic, with the S&P 500, Nasdaq, and Dow each gaining 0.5% for the day and week, shrugging off concerns regarding regional bank loans and U.S.-China trade tensions. Other notable positive movers included Gilead Sciences (GILD), up 4.2% on positive Phase 3 trial results and a Goldman Sachs price target boost, and Truist Financial (TFC), which rose 3.7% following better-than-expected Q3 results fueled by strong fee income. Kenvue (KVUE) also recovered 8.4% after prior session losses. Conversely, several stocks faced significant pressure. Newmont (NEM), the world's largest gold producer, dropped 7.6% as gold prices retreated from record levels. Oracle (ORCL) sank nearly 7% due to analyst concerns over capital expenditure transparency and customer concentration, despite projecting robust long-term growth. Moderna (MRNA) also declined 4.2% amid worries about decreasing COVID-19 vaccine revenue and limited product diversification efforts.

AllMind AI Terminal